title: Chronic ethanol consumption in rats produces opioid antinociceptive tolerance through inhibition of mu opioid receptor endocytosis.
abstract: It is well known that the mu-opioid receptor (MOR) plays an important role in the rewarding properties of ethanol. However, it is less clear how chronic ethanol consumption affects MOR signaling. Here, we demonstrate that rats with prolonged voluntary ethanol consumption develop antinociceptive tolerance to opioids. Signaling through the MOR is controlled at many levels, including via the process of endocytosis. Importantly, agonists at the MOR that promote receptor endocytosis, such as the endogenous peptides enkephalin and β-endorphin, show a reduced propensity to promote antinociceptive tolerance than do agonists, like morphine, which do not promote receptor endocytosis. These observations led us to examine whether chronic ethanol consumption produced opioid tolerance by interfering with MOR endocytosis. Indeed, here we show that chronic ethanol consumption inhibits the endocytosis of MOR in response to opioid peptide. This loss of endocytosis was accompanied by a dramatic decrease in G protein coupled receptor kinase 2 (GRK2) protein levels after chronic drinking, suggesting that loss of this component of the trafficking machinery could be a mechanism by which endocytosis is lost. We also found that MOR coupling to G-protein was decreased in ethanol-drinking rats, providing a functional explanation for loss of opioid antinociception. Together, these results suggest that chronic ethanol drinking alters the ability of MOR to endocytose in response to opioid peptides, and consequently, promotes tolerance to the effects of opioids.
authors: Ernest Gallo Clinic and Research Center, University of California, Emeryville, California, United States of America.
authors: Li
authors: L
authors: He
authors: Jennifer L
authors: JL
authors: Whistler
references: Curr Biol. 2008 Jan 22;18(2):129-35
references: 18207746
references: Neuroscience. 2007 Feb 9;144(3):777-82
references: 17156932
references: Alcohol Clin Exp Res. 2008 Oct;32(10):1816-23
references: 18671810
references: Alcohol Clin Exp Res. 1997 Jun;21(4):754-62
references: 9194936
references: J Neurosci. 2000 Dec 1;20(23):8578-84
references: 11102461
references: J Pharmacol Exp Ther. 2002 Jan;300(1):265-72
references: 11752125
references: J Neurosci. 1996 Apr 15;16(8):2684-92
references: 8786444
references: Eur J Pharmacol. 1993 Sep 7;241(1):63-70
references: 8223926
references: Alcohol Clin Exp Res. 2007 Aug;31(8):1435-40
references: 17550364
references: Psychopharmacology (Berl). 2007 Jun;192(2):207-17
references: 17273875
references: Anesthesiology. 1990 Dec;73(6):1141-7
references: 1978988
references: Psychopharmacology (Berl). 2001 Mar 1;154(2):131-42
references: 11314675
references: J Clin Invest. 2008 Mar;118(3):1065-73
references: 18246198
references: Alcohol Clin Exp Res. 2002 May;26(5):688-94
references: 12045478
references: Proc Natl Acad Sci U S A. 1998 Aug 18;95(17):9914-9
references: 9707575
references: Pharmacology. 2007;79(4):193-202
references: 17356311
references: JAMA. 2006 May 3;295(17):2003-17
references: 16670409
references: Psychopharmacology (Berl). 2008 Dec;201(2):261-71
references: 18688603
references: Cell. 2002 Jan 25;108(2):271-82
references: 11832216
references: J Neurosci. 2001 Dec 1;21(23):RC184
references: 11717387
references: J Pharmacol Exp Ther. 2000 Dec;295(3):1012-21
references: 11082436
references: J Pain. 2009 Apr;10(4):369-79
references: 19327642
references: Psychopharmacology (Berl). 2004 Apr;173(1-2):32-40
references: 14722705
references: J Neurosci. 2001 May 1;21(9):2967-73
references: 11312280
references: Proc Natl Acad Sci U S A. 2003 Jan 7;100(1):277-82
references: 12493843
references: J Pharmacol Exp Ther. 2000 Jun;293(3):1002-8
references: 10869404
references: J Neurochem. 2004 Feb;88(3):680-8
references: 14720217
references: Psychopharmacology (Berl). 2003 Aug;169(1):60-7
references: 12759807
references: Brain Res. 2001 Mar 23;895(1-2):1-8
references: 11259753
references: Anesthesiology. 1995 May;82(5):1226-36
references: 7741298
references: Psychopharmacology (Berl). 1997 Jan;129(2):99-111
references: 9040115
references: Alcohol Clin Exp Res. 2004 Jan;28(1):98-104
references: 14745307
references: Alcohol. 1997 Jul-Aug;14(4):361-6
references: 9209551
references: Arch Gen Psychiatry. 1992 Nov;49(11):876-80
references: 1345133
references: Mol Pharmacol. 2004 Mar;65(3):528-37
references: 14978231
references: Proc Natl Acad Sci U S A. 1995 Aug 1;92(16):7242-6
references: 7638174
references: Nat Neurosci. 1999 Dec;2(12):1091-7
references: 10570486
references: Psychopharmacology (Berl). 2001 Feb;154(1):43-9
references: 11292005
references: Curr Biol. 2005 Jun 7;15(11):1028-33
references: 15936273
references: Arch Gen Psychiatry. 1992 Nov;49(11):881-7
references: 1444726
references: Proc Natl Acad Sci U S A. 1998 Jun 9;95(12):7157-62
references: 9618555
references: J Pharmacol Exp Ther. 1995 Oct;275(1):518-27
references: 7562594
references: J Pharmacol Toxicol Methods. 1994 Dec;32(4):197-200
references: 7881133
references: Psychopharmacology (Berl). 2006 Jun;186(2):177-84
references: 16572262
references: Neuron. 1999 Aug;23(4):737-46
references: 10482240
references: Alcohol Clin Exp Res. 2005 Aug;29(8):1522-7
references: 16156049
references: Mol Pharmacol. 2006 Aug;70(2):676-85
references: 16682505
references: Circ Res. 2006 Sep 15;99(6):570-82
references: 16973913
references: J Pharmacol Exp Ther. 2000 Apr;293(1):159-65
references: 10734165
references: Ann Neurol. 2010 May;67(5):559-69
references: 20437553
references: Genes Brain Behav. 2007 Nov;6(8):728-35
references: 17428267